Reply to “SARS1 (SerRS) Causing De Novo Dominant Charcot–Marie–Tooth Disease with Slow Conduction”

Annals of NeurologyEarly View Reply Reply to “SARS1 (SerRS) Causing De Novo Dominant Charcot–Marie–Tooth Disease with Slow Conduction” Jin He MD, Jin He MD orcid.org/0000-0002-2175-0885 Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China J.H. and X.-X.L. contributed equally to this work.Search for more papers by this authorXiao-Xuan Liu MD, PhD, Xiao-Xuan Liu MD, PhD Department of Neurology of Peking University Third Hospital, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, China J.H. and X.-X.L. contributed equally to this work.Search for more papers by this authorDong-Sheng Fan MD, PhD, Corresponding Author Dong-Sheng Fan MD, PhD [email protected] Department of Neurology of Peking University Third Hospital, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, China Address correspondence to Dr Chen, Department of Neurology, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. E-mail: [email protected]; and Dr Fan, Department of Neurology, Peking University Third Hospital, Beijing, 100191, China. E-mail: [email protected]Search for more papers by this authorWan-Jin Chen, Corresponding Author Wan-Jin Chen [email protected] orcid.org/0000-0002-9472-8494 Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China Address correspondence to Dr Chen, Department of Neurology, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. E-mail: [email protected]; and Dr Fan, Department of Neurology, Peking University Third Hospital, Beijing, 100191, China. E-mail: [email protected]Search for more papers by this author Jin He MD, Jin He MD orcid.org/0000-0002-2175-0885 Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China J.H. and X.-X.L. contributed equally to this work.Search for more papers by this authorXiao-Xuan Liu MD, PhD, Xiao-Xuan Liu MD, PhD Department of Neurology of Peking University Third Hospital, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, China J.H. and X.-X.L. contributed equally to this work.Search for more papers by this authorDong-Sheng Fan MD, PhD, Corresponding Author Dong-Sheng Fan MD, PhD [email protected] Department of Neurology of Peking University Third Hospital, Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, China Address correspondence to Dr Chen, Department of Neurology, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. E-mail: [email protected]; and Dr Fan, Department of Neurology, Peking University Third Hospital, Beijing, 100191, China. E-mail: [email protected]Search for more papers by this authorWan-Jin Chen, Corresponding Author Wan-Jin Chen [email protected] orcid.org/0000-0002-9472-8494 Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China Address correspondence to Dr Chen, Department of Neurology, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. E-mail: [email protected]; and Dr Fan, Department of Neurology, Peking University Third Hospital, Beijing, 100191, China. E-mail: [email protected]Search for more papers by this author First published: 13 September 2023 https://doi.org/10.1002/ana.26790 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1He J, Liu XX, Ma MM, et al. Heterozygous Seryl-tRNA synthetase 1 variants cause Charcot-Marie-tooth disease[J]. Ann Neurol 2023; 93: 244–256. 2Spaulding EL, Hines TJ, Bais P, et al. The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy[J]. Science 2021; 373: 1156–1161. 3Zuko A, Mallik M, Thompson R, et al. tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase[J]. Science 2021; 373: 1161–1166. 4Cui Q, Bi H, Lv Z, et al. Diverse CMT2 neuropathies are linked to aberrant G3BP interactions in stress granules[J]. Cell 2023; 186: 803–820.e25. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation